| abstract |
The present specification relates to compounds, forms and pharmaceutical compositions thereof, and methods of using such compounds, forms or compositions for treating or ameliorating Huntington's disease. In particular, the present specification describes substituted benzothiazole compounds of formula (I) or (II), their forms and pharmaceutical compositions, and such compounds, forms or forms thereof for treating or ameliorating Huntington's disease. Regarding the method of using the composition. [Chemical 1] |